Cancer Incidence and Mortality for Orleans County, 2012-2016

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males and Females Males Females Males and Females Males Females
Average Annual Cases Rate per 100,000 Population 95% CI Average Annual Cases Rate per 100,000 Males 95% CI Average Annual Cases Rate per 100,000 Females 95% CI Average Annual Deaths Rate per 100,000 Population 95% CI Average Annual Deaths Rate per 100,000 Males 95% CI Average Annual Deaths Rate per 100,000 Females 95% CI
All Invasive Malignant Tumors 276.4 526.6 498.4-556.0 144.4 587.2 543.8-633.3 132.0 481.8 444.6-521.5 97.4 182.8 166.6-200.3 50.4 214.5 188.0-243.8 47.0 162.8 142.2-185.9
Oral cavity and pharynx 6.0 11.0 7.3-16.0 4.2 16.5 10.0-25.9 1.8 6.2 2.8-12.4 1.6 3.3 1.4-6.8 0.8 4.1 1.0-10.7 0.8 2.8 0.7-7.8
Esophagus 3.4 5.5 3.1-9.1 3.0 9.9 5.5-17.1 0.4 1.2 0.1-5.3 3.2 6.1 3.4-10.1 2.4 9.8 5.0-17.7 0.8 3.0 0.8-8.2
Stomach 4.4 8.2 5.1-12.6 3.4 14.0 8.0-22.9 1.0 3.6 1.1-9.1 1.4 2.6 1.0-5.7 1.4 6.2 2.4-13.1 0.0 0.0 0.0-3.7
Colorectal 23.8 45.7 37.6-55.0 11.8 47.8 36.0-62.5 12.0 42.6 32.3-55.5 9.6 17.8 13.0-24.0 5.8 24.4 16.1-35.6 3.8 12.8 7.6-20.5
Colon excluding rectum 14.8 28.7 22.4-36.4 6.8 28.1 19.1-40.0 8.0 28.5 20.1-39.5 8.0 15.1 10.7-20.9 5.0 21.3 13.5-32.0 3.0 10.3 5.7-17.6
Rectum & rectosigmoid 9.0 17.0 12.3-23.0 5.0 19.7 12.6-29.7 4.0 14.1 8.6-22.4 1.6 2.7 1.2-5.7 0.8 3.1 0.8-8.6 0.8 2.5 0.7-7.2
Liver / intrahepatic bile duct 5.0 8.5 5.4-12.8 2.8 9.9 5.3-17.2 2.2 6.9 3.4-13.0 4.2 7.8 4.8-12.2 1.8 7.5 3.4-14.8 2.4 8.2 4.2-15.0
Pancreas 8.2 15.7 11.2-21.6 4.0 15.4 9.2-24.3 4.2 15.3 9.4-24.0 6.4 12.3 8.3-17.6 3.2 12.4 7.0-20.7 3.2 12.1 6.8-20.3
Larynx 2.0 3.4 1.6-6.6 1.4 5.5 2.1-11.9 0.6 1.9 0.4-6.4 1.0 1.6 0.5-4.2 0.6 2.2 0.4-7.1 0.4 1.2 0.1-5.4
Lung and bronchus 45.2 83.7 72.9-95.8 23.4 94.9 78.0-114.6 21.8 75.8 61.9-92.1 31.0 57.4 48.5-67.5 14.4 58.6 45.5-74.6 16.6 56.7 45.0-70.9
Melanoma of the skin 16.2 33.8 26.6-42.5 9.0 39.0 28.1-52.8 7.2 29.8 20.4-42.1 1.4 2.8 1.1-6.2 0.6 2.7 0.5-8.1 0.8 3.2 0.7-8.9
Female breast             30.0 110.0 92.7-129.8             4.0 13.9 8.4-22.0
Cervix uteri             1.2 5.2 1.8-11.7             0.8 2.7 0.7-7.7
Corpus uterus and NOS             10.8 38.0 28.3-50.3             1.0 3.8 1.2-9.5
Ovary             3.2 10.9 6.2-18.2             1.6 5.3 2.2-11.1
Prostate       28.6 106.8 89.6-126.5             3.2 15.7 8.9-25.6      
Testis       1.8 8.9 4.0-17.1             0.0 0.0 0.0-3.8      
Urinary bladder (incl. in situ) 17.8 33.2 26.6-41.1 14.2 58.0 45.0-73.8 3.6 12.3 7.2-20.1 3.8 7.6 4.5-12.0 3.0 14.4 7.9-24.0 0.8 2.6 0.7-7.4
Kidney and renal pelvis 10.8 21.6 16.0-28.5 7.4 31.1 21.5-43.5 3.4 12.6 7.2-20.8 1.6 2.7 1.1-5.6 1.2 4.0 1.4-9.5 0.4 1.3 0.1-5.6
Brain and other central nervous system 2.4 5.3 2.6-9.5 1.2 5.5 2.0-12.3 1.2 5.1 1.7-11.8 3.2 6.1 3.4-10.3 1.2 4.7 1.6-10.9 2.0 7.2 3.2-14.0
Thyroid 7.4 14.4 10.0-20.2 1.4 5.2 2.0-11.4 6.0 23.6 15.6-34.4 0.2 0.4 0.0-2.4 0.2 1.1 0.0-6.0 0.0 0.0 0.0-3.7
Hodgkin lymphoma 1.4 3.5 1.4-7.3 0.2 1.3 0.0-6.5 1.2 5.7 2.0-12.6 0.0 0.0 0.0-1.9 0.0 0.0 0.0-3.8 0.0 0.0 0.0-3.7
Non-Hodgkin lymphomas 9.8 19.2 14.0-25.6 4.4 18.8 11.6-29.0 5.4 20.3 13.2-30.2 4.2 8.3 5.1-13.0 1.8 9.0 4.1-17.1 2.4 8.3 4.2-15.2
Myeloma 2.2 4.2 2.0-7.8 1.0 4.5 1.4-10.9 1.2 4.3 1.5-10.1 0.6 1.2 0.3-3.8 0.6 3.1 0.6-9.1 0.0 0.0 0.0-3.7
Leukemias 10.0 20.2 14.8-26.9 6.8 28.2 19.3-40.0 3.2 13.1 7.2-22.0 3.6 7.1 4.2-11.5 2.4 10.7 5.5-19.1 1.2 4.4 1.5-10.4

Notes

  • Incidence data are provisional, November 2018.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.